Literature DB >> 19698711

Trypanosoma cruzi: biodistribution of technetium-99m pertechnetate in infected rats.

Vanessa S A Barbosa1, Cecília M C X Holanda, Antônia C J Câmara, Roseane P Silva, Daniel P Oliveira, Jeanete A Moreira, Aldo C Medeiros.   

Abstract

With the aim of investigating the biodistribution of technetium-99m pertechnetate ((99m)TcO4-) in rats infected with Y strain of Tripanosoma Cruzi, at the peak of parasitemia, (14th day of infection), we injected Wistar rats with 0.1 ml of (99m)TcO4- (3.7MBq). After 60 min, the percentage of radioactivity per gram was counted in several isolated organs and blood, using a gamma counter (1470 Wizard, PerkinElmer Finland). The uptake of (99m)TcO4- increased significantly in blood and decreased in the colon of infected animals (p<0.05). A significant reduction in serum iron and red blood cells and a significant increase in total proteins, leukocytes and lymphocytes in the infected rats were observed, compared with controls (p<0.05). A reduction in muscle layer thickness of the colon and mononuclear inflammation were observed. These results conclusively demonstrate that T. cruzi infection would be associated with changes in the biodistribution of (99m)TcO4- and in colon morphology, with potential clinical implications.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19698711     DOI: 10.1016/j.exppara.2009.08.006

Source DB:  PubMed          Journal:  Exp Parasitol        ISSN: 0014-4894            Impact factor:   2.011


  2 in total

1.  Activity of cholinesterases and adenosine deaminase in blood and serum of rats experimentally infected with Trypanosoma cruzi.

Authors:  A S Da Silva; V C Pimentel; A M Fiorenza; R T França; A A Tonin; J A Jaques; C A M Leal; C B Da Silva; V Morsch; M R C Sschetinger; S T A Lopes; S G Monteiro
Journal:  Ann Trop Med Parasitol       Date:  2011-07

2.  Biodistribution and Efficacy of Targeted Pulmonary Delivery of a Protein Kinase C-δ Inhibitory Peptide: Impact on Indirect Lung Injury.

Authors:  Mark J Mondrinos; Linda C Knight; Paul A Kennedy; Jichuan Wu; Matthew Kauffman; Sandy T Baker; Marla R Wolfson; Laurie E Kilpatrick
Journal:  J Pharmacol Exp Ther       Date:  2015-08-04       Impact factor: 4.030

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.